Pharmaceuticals company Wockhardt announced Q4FY25 & FY25 results Q4FY25 Financial Highlights: Revenue for Q4FY25 of Rs 743 crore compared to Rs 750 crore in the previous year. QoQ growth of 13% in EBITDA in Q4FY25, EBITDA for Q4FY25 of Rs 79 crore compared to Rs 70 crore in the previous year. FY25 Financial Highlights: Revenue for FY25 of Rs 3,033 crore compared to Rs 2,879 crore in the previous year. YoY growth of 67% in EBITDA in FY25, EBITDA for FY25 of Rs 418 crore compared to Rs 251 crore in the previous year. Result PDF